Skip to main content
PepStack
Hormone · Profile

Nerve Growth Factor

NGF · Beta-NGF

Growth FactorsApproved
MW
325.27g/mol
Formula
C11H19NO10

Nerve Growth Factor (NGF) is a neurotrophin primarily produced in the nervous system, with significant roles in neuronal survival, differentiation, and maintenance. Researchers primarily study NGF for its involvement in various biological processes, including sensory innervation, immune regulation, and reproductive functions. Key findings indicate that NGF promotes sensory nerve growth, which can influence inflammation and tissue regeneration, while also playing a role in reproductive physiology, such as luteal function in cattle. Additionally, clinical evidence suggests that NGF has potential applications in treating ocular diseases and managing pain conditions, highlighting its multifaceted roles in health and disease. Current research continues to explore NGF's diverse functions and therapeutic potential across various medical fields.

Overview

Übersicht

Nerve Growth Factor (NGF), also known as Beta-NGF, is an endogenous neurotrophin primarily produced in the central and peripheral nervous systems. It belongs to the chemical class of growth factors and is crucial for the survival, development, and function of neurons. NGF is synthesized by various cell types, including neurons, immune cells, and epithelial cells, and is found in seminal plasma, highlighting its diverse physiological roles. Researchers have observed that NGF plays a pivotal role in sensory innervation, tissue repair, and immunoregulation. It is involved in the modulation of inflammation and has been studied for its potential in promoting tissue regeneration, particularly in bone and neural tissues. NGF also influences mesenchymal stem/stromal cells (MSCs), affecting their survival, growth, and differentiation. The mechanism of action of NGF involves binding to its high-affinity receptor TrkA and low-affinity receptor p75NTR, initiating signaling pathways that promote neuronal survival and differentiation. In reproductive biology, NGF has been identified as an ovulation-inducing factor in camelids and is being explored for its luteotropic effects in bovine species. Pharmacokinetic properties of NGF, such as half-life and metabolism, are not well-documented in the literature. However, recombinant human NGF has been used in clinical trials for ocular conditions like neurotrophic keratopathy and glaucoma, demonstrating safety and efficacy. NGF's potential as a treatment for pediatric eye diseases and as an analgesic for pain management is under investigation. Regulatory standing varies by region, with ongoing research into its therapeutic applications.

Chemical profile

Chemische Struktur

Chemical structure of Nerve Growth Factor
FormelC11H19NO10
Molekulargewicht325.27g/mol
CAS-Nummer1113-83-3
PubChem CID60160600
Mechanism

Wirkmechanismus

NGF acts primarily through its high-affinity receptor TrkA and low-affinity receptor p75NTR. Upon binding to TrkA, NGF activates downstream signaling pathways such as the MAPK/ERK and PI3K/Akt pathways, promoting neuronal survival, differentiation, and growth. The interaction with p75NTR can modulate these effects and is involved in apoptosis and cell survival decisions.

Mechanism

Signalweg

Nerve Growth Factor (NGF) primarily exerts its effects through binding to two receptors: TrkA and p75NTR. Activation of TrkA initiates the PI3K/Akt and MAPK/ERK signaling pathways, promoting neuronal survival, differentiation, and angiogenesis, while p75NTR is involved in modulating apoptosis and neurotrophic signaling. The precise mechanisms of NGF's actions, particularly in non-neuronal contexts such as mesenchymal stem/stromal cells and immune modulation, remain incompletely understood.

Half-Life & Pharmacokinetics

Pharmacokinetic data for NGF is limited, particularly regarding its half-life and metabolism in different administration routes.

Storage

Temperature

Refrigerate at 2-8C

Light

Protect from light

Form

Aqueous solution: use within specified period as per manufacturer

Notes

Ensure proper storage conditions to maintain stability and efficacy of NGF formulations.

Solubility

Löslichkeit

NGF is soluble in aqueous solutions, which is relevant for its formulation in clinical applications.

Legal Status

🇩🇪DE

Data limited

🇺🇸US

Data limited

🇦🇺AU

Data limited

🇬🇧UK

Data limited

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

Open Questions

Offene Forschungsfragen

Current evidence is limited regarding the specific mechanisms through which nerve growth factor (NGF) interacts with mesenchymal stem/stromal cells (MSCs) and how these interactions can be optimized for therapeutic applications. Further research is needed to clarify the contradictory findings related to NGF's role in reproductive physiology, particularly in bovine species, and to establish the clinical relevance of NGF in pediatric eye diseases through larger randomized controlled trials (RCTs) that assess long-term outcomes. Additionally, the safety and efficacy of NGF antagonism in pain management require more extensive studies to understand the expression patterns and functional roles of NGF in different populations and conditions.

76 Research Publications

3,130

Total Citations

12

Human/RCT

4.0

Avg. Influence

2025

Latest

Sort
Filter
#01

Nerve growth factor and nociception.

AnimalInfluence19.0
545
Researchers observed that nerve growth factor (NGF) is crucial for the survival and normal phenotypic development of nociceptive sensory neurons during development and plays a role in linking inflammation to hyperalgesia in adulthood.
#02

Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.

In VitroInfluence10.0
414
The study demonstrated that a heparin-containing fibrin matrix can control the release of beta-nerve growth factor, enhancing neurite extension in a cell culture model.
#03

Nerve Growth Factor and Pain Mechanisms.

Denk Franziska, et al. · Annual review of neuroscience · 2017

ReviewInfluence12.0
231
Researchers observed that antagonism of nerve growth factor (NGF) is emerging as a promising analgesic strategy for conditions like osteoarthritis and lower back pain, despite ongoing questions regarding NGF's mechanisms.

Key findings

  1. 01NGF antagonism shows promise as a pain relief treatment.
  2. 02There is still much to learn about NGF's role in persistent pain.
  3. 03Potential side effects of anti-NGF therapy need further investigation.
#04

Nerve Growth Factor: Early Studies and Recent Clinical Trials.

ReviewInfluence6.0
184
Researchers observed that nerve growth factor (NGF) has therapeutic potential for various human conditions, including ocular diseases and brain traumas, based on extensive clinical studies demonstrating its regulatory functions.
#05

Nerve growth factor as an angiogenic factor.

ReviewInfluence8.0
180
The review summarized that nerve growth factor plays a significant role in angiogenesis and endothelial cell function, highlighting its potential implications in both normal and pathological conditions.
#06

Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen.

AnimalInfluence1.0
122
Researchers observed that endogenous nerve growth factor expression in the rat caudate-putamen is temporally regulated and correlates with cholinergic neurochemical differentiation.
#07

beta-Nerve growth factor (beta NGF) receptors on glial cells. Cell-cell interaction between neurones and Schwann cells in cultures of chick sensory ganglia.

In Vitro
115
Researchers observed that beta-nerve growth factor receptors are expressed on non-neuronal cells in chick dorsal root ganglia, indicating their involvement in neuron-Schwann cell interactions.
#08

Human beta-nerve growth factor gene sequence highly homologous to that of mouse.

In VitroInfluence2.0
89
The study demonstrated that the human beta-nerve growth factor gene is highly homologous to the mouse gene, suggesting evolutionary conservation of its function.
#09

Nerve growth factor (NGF) receptor expression in chicken cranial development.

In Vitro
82
The study demonstrated specific binding of beta-nerve growth factor to various cranial cells during chicken development, indicating its diverse roles in tissue growth and differentiation.
#10

Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth.

Animal
81
The study demonstrated that nerve growth factor beta (NGF beta) delivered via a collagen/hydroxyapatite composite significantly stimulated bone formation and remodeling in calvaria defects of Wistar rats.

Clinical Trials (8)

Preclinical
Phase I
Phase II
Phase III
Approved

8

Total Trials

796

Total Enrolled

Assessment of the Effects of Extensive Somatosensory Training on Pain Processing

NCT04457466TERMINATED
Sponsor

Aalborg University

Enrollment

100

Started

2017

Primary outcome

Pain rating

Musculoskeletal Pain

Treatment of Cerebral Radiation Necrosis (CRN) With Nerve Growth Factor (NGF)

NCT02032147COMPLETED
Sponsor

Fudan University

Enrollment

30

Started

2009

Primary outcome

efficacy of using NGF for treating CRN

Cerebral NecrosisNashopharyngeal CancerNerve Growth Factor

Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease

NCT04041349Phase 4UNKNOWN
Sponsor

Zhujiang Hospital

Enrollment

50

Started

2019

Primary outcome

change of Alzheimer's disease assessment scale-cognition (ADAS-cog) score

Cerebral Small Vessel Diseases

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

NCT00000842Phase 2COMPLETED
Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment

270

HIV InfectionsPeripheral Nervous System Disease

An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye

NCT03019627Phase 2COMPLETED
Sponsor

Dompé Farmaceutici S.p.A

Enrollment

150

Started

2017

Primary outcome

Symptom Assessment in Dry Eye (SANDE) Scores

Dry Eye

Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury

NCT01212679Phase 2COMPLETED
Sponsor

Jinling Hospital, China

Enrollment

106

Started

2010

Primary outcome

improved neurological functions

Traumatic Brain Injury

Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma

NCT02855450Phase 1COMPLETED
Sponsor

Dompé Farmaceutici S.p.A

Enrollment

60

Started

2016

Primary outcome

Incidence of Events as of Primary Safety Outcomes

Glaucoma

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

NCT03836859Phase 1COMPLETED
Sponsor

Dompé Farmaceutici S.p.A

Enrollment

30

Started

2018

Primary outcome

Number of Treatment Emergent Adverse Events (TEAEs).

Healthy Volunteers

Track your hormone research in PepStack

Log cycles, set reminders and visualize serum levels.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer